Navidea Biopharmaceuticals is a company that specializes in developing and commercializing precision immunodiagnostic agents and immunotherapeutics. The company operates through two segments, Diagnostic Substances and Therapeutic Development Programs. Navidea Biopharmaceuticals has developed a Manocept platform for delivering therapeutic compounds to target macrophages, and immune- and inflammation-involved diseases.